Summit Clinical Research: Comprehensive Company Profile

Background

Overview

Summit Clinical Research is a physician-founded Integrated Research Organization (IRO) established in 2018, headquartered in San Antonio, Texas. The organization specializes in advancing clinical trials for therapeutic areas such as Steatotic Liver Disease (SLD), obesity, and Alzheimer's disease. Summit offers a comprehensive suite of services, including site activation, patient recruitment, biostatistics, and operational oversight, to support Phase II and III clinical trials.

Mission and Vision

Summit's mission is to execute comprehensive site recruitment and engagement strategies that efficiently and cost-effectively achieve target patient enrollment within projected study timelines. The vision is to support clinical trial sponsors, research physicians, and investigator sites equally, fostering innovation and collaboration to define the future of therapeutically focused research.

Industry Significance

Since its inception, Summit Clinical Research has become a significant player in the clinical research industry, particularly in the domains of SLD, obesity, and Alzheimer's disease. The organization has supported over 60 clinical trials, collaborated with more than 70 biopharmaceutical sponsors, and established a network of over 120 research sites across eight countries.

Key Strategic Focus

Core Objectives

Summit Clinical Research aims to accelerate the development of new therapies by providing high-quality, reliable data while upholding the highest standards of patient safety and ethical conduct. The organization focuses on efficient site activation, patient recruitment, and operational excellence to support the successful execution of clinical trials.

Areas of Specialization

Summit's primary areas of specialization include:

Steatotic Liver Disease (SLD): Including Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and Alcohol-Related Liver Disease (ALD).

Obesity: Focusing on clinical trials related to obesity and its associated comorbidities.

Alzheimer's Disease: Conducting research to advance treatments for Alzheimer's disease.

Key Technologies Utilized

Summit employs a range of technologies to enhance clinical trial execution, including:

Patient Recruitment Platforms: Utilizing customizable patient engagement platforms with embedded pre-screening questionnaires to streamline patient recruitment.

Biostatistics and Statistical Programming: Providing dedicated biostatistics services tailored to studies in MASH, obesity, and Alzheimer's disease.

Primary Markets Targeted

Summit primarily targets the following markets:

Pharmaceutical and Biotechnology Companies: Offering comprehensive clinical trial support services.

Contract Research Organizations (CROs): Collaborating to enhance clinical trial execution.

Research Sites: Providing site activation, recruitment, and operational support.

Financials and Funding

Funding History

As of March 2026, Summit Clinical Research has not publicly disclosed specific details regarding its funding history, total funds raised, or individual funding rounds. The organization remains privately held and has not announced any recent funding events.

Recent Developments

In October 2022, Summit Clinical Research was acquired by LongueVue Capital, a private equity firm, to accelerate its growth and expansion in the clinical research sector.

Utilization of Capital

While specific details on the utilization of capital are not publicly disclosed, the acquisition by LongueVue Capital is expected to support Summit's strategic initiatives, including expanding its global site network, enhancing technological capabilities, and advancing its therapeutic research focus.

Pipeline Development

Key Pipeline Candidates

Summit Clinical Research does not develop its own pharmaceutical products but plays a pivotal role in supporting the development of treatments in the following areas:

Steatotic Liver Disease (SLD): Including MASH, MASLD, and ALD.

Obesity: Focusing on clinical trials related to obesity and its associated comorbidities.

Alzheimer's Disease: Conducting research to advance treatments for Alzheimer's disease.

Stages of Clinical Trials

Summit supports Phase II and III clinical trials, providing services such as site activation, patient recruitment, biostatistics, and operational oversight.

Target Conditions

The organization focuses on the following target conditions:

Steatotic Liver Disease (SLD): Including MASH, MASLD, and ALD.

Obesity: Focusing on clinical trials related to obesity and its associated comorbidities.

Alzheimer's Disease: Conducting research to advance treatments for Alzheimer's disease.

Anticipated Milestones

While specific timelines for anticipated milestones are not publicly disclosed, Summit's strategic initiatives, including the expansion of its global site network and enhancement of technological capabilities, are expected to contribute to the successful execution of clinical trials and the advancement of treatments in its focus areas.

Technological Platform and Innovation

Proprietary Technologies

Summit Clinical Research utilizes proprietary technologies to enhance clinical trial execution, including:

Patient Recruitment Platforms: Customizable platforms with embedded pre-screening questionnaires to streamline patient recruitment.

Biostatistics and Statistical Programming: Dedicated services tailored to studies in MASH, obesity, and Alzheimer's disease.

Significant Scientific Methods

Summit employs various scientific methods to support clinical trials, including:

Clinical Trial Management: Providing strategic guidance on protocol development and robust support for drug development.

Patient Recruitment Strategies: Implementing community engagement initiatives and multi-channel marketing strategies to reach diverse patient populations.

AI-Driven Capabilities

While specific details on AI-driven capabilities are not publicly disclosed, Summit's focus on operational excellence and patient recruitment suggests the potential integration of advanced technologies to enhance clinical trial execution.

Leadership Team

Key Executives

Gail Hinkson: Chief Executive Officer (CEO).

Brandon Early: President.

Dr. Mazen Noureddin: Chief Scientific Officer.

Genevieve Long: Chief Operations Officer.

Professional Backgrounds and Contributions

Detailed professional backgrounds and specific contributions of the leadership team are not publicly disclosed. However, the team's expertise spans clinical research, operations, and scientific development, contributing to Summit's growth and success in the clinical research sector.

Competitor Profile

Market Insights and Dynamics

The clinical research industry is characterized by a growing demand for efficient and effective clinical trial execution, particularly in specialized therapeutic areas such as SLD, obesity, and Alzheimer's disease. Organizations like Summit Clinical Research play a crucial role in bridging the gap between pharmaceutical sponsors and research sites, facilitating the development of new therapies.

Competitor Analysis

Summit Clinical Research operates in a competitive landscape with several key players, including:

Alimentiv Inc.: A specialized contract research organization focusing on gastrointestinal treatments, including NASH.

PathAI Inc.: A company specializing in AI-driven pathology solutions, collaborating with organizations like Summit to enhance clinical trial outcomes.

Tekton Research: A clinical research site network conducting Phase 1-4 trials in CNS, cardiometabolic, general medicine, and infectious disease, partnering with Summit to expand into MASH/NASH trials.

Strategic Collaborations and Partnerships

Summit Clinical Research has engaged in strategic collaborations to enhance its capabilities, including:

Alimentiv Inc.: Partnered to drive NASH clinical trials.

PathAI Inc.: Collaborated to integrate AI-driven pathology solutions into clinical trials.

Tekton Research: Partnered to expand into MASH/NASH trials.

Operational Insights

Summit's extensive site network and focus on operational excellence provide a competitive advantage in executing complex clinical trials efficiently. The organization's commitment to patient recruitment and retention strategies further strengthens its position in the market.

summit-clinical-research